David P. Bingaman

Person

Forth Worth, TX, US

People

Patents Grantslast 30 patents

Information Patent Grant
Ocular formulations for drug-delivery to the posterior segment of t...
- Patent number 10,307,404
- Issue date Jun 4, 2019
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery and protection of the anterio...
- Patent number 10,183,014
- Issue date Jan 22, 2019
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery to the posterior segment of t...
- Patent number 10,092,549
- Issue date Oct 9, 2018
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery and protection of the anterio...
- Patent number 9,814,702
- Issue date Nov 14, 2017
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery and protection of the anterio...
- Patent number 9,623,011
- Issue date Apr 18, 2017
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery to the posterior segment of t...
- Patent number 9,446,026
- Issue date Sep 20, 2016
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-related inhibition of TNF-alpha signaling pathway for treatmen...
- Patent number 9,422,556
- Issue date Aug 23, 2016
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi-related inhibition of TNF alpha signaling pathway for treatmen...
- Patent number 9,139,834
- Issue date Sep 22, 2015
- Arrowhead Research Corporation
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
- Patent number 8,940,887
- Issue date Jan 27, 2015
- Alcon Research, Ltd.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-related inhibition of TNFα signaling pathway for treatment of...
- Patent number 8,865,670
- Issue date Oct 21, 2014
- Alcon Research, Ltd.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi-related inhibition of TNFα signaling pathway for treatment of...
- Patent number 8,754,202
- Issue date Jun 17, 2014
- Alcon Research, Ltd.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treatment of angiogenesis-associated o...
- Patent number 8,722,015
- Issue date May 13, 2014
- The Schepens Eye Research Institute, Inc.
- Andrius Kazlauskas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
- Patent number 8,471,000
- Issue date Jun 25, 2013
- Alcon Research, Ltd.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis
- Patent number 7,981,870
- Issue date Jul 19, 2011
- Alcon Research, Ltd.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocu...
- Patent number 7,879,905
- Issue date Feb 1, 2011
- Alcon, Inc.
- Peter G. Klimko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20240325357
- Publication date Oct 3, 2024
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20240277674
- Publication date Aug 22, 2024
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20220364097
- Publication date Nov 17, 2022
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20220162614
- Publication date May 26, 2022
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20220042021
- Publication date Feb 10, 2022
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20210275501
- Publication date Sep 9, 2021
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20210230603
- Publication date Jul 29, 2021
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20210196690
- Publication date Jul 1, 2021
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20210108206
- Publication date Apr 15, 2021
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20200392508
- Publication date Dec 17, 2020
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20200277608
- Publication date Sep 3, 2020
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20200165615
- Publication date May 28, 2020
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20200048637
- Publication date Feb 13, 2020
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20190338287
- Publication date Nov 7, 2019
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20190314343
- Publication date Oct 17, 2019
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20190256854
- Publication date Aug 22, 2019
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20190247368
- Publication date Aug 15, 2019
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20190240201
- Publication date Aug 8, 2019
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20190183864
- Publication date Jun 20, 2019
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20190144866
- Publication date May 16, 2019
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20190071676
- Publication date Mar 7, 2019
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20180078531
- Publication date Mar 22, 2018
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20170198294
- Publication date Jul 13, 2017
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20160354349
- Publication date Dec 8, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...
- Publication number 20160326533
- Publication date Nov 10, 2016
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20160206599
- Publication date Jul 21, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ocular Formulations for Drug-Delivery and Protection of the Anterio...
- Publication number 20160074371
- Publication date Mar 17, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ocular Formulations for Drug-Delivery to the Posterior Segment of t...
- Publication number 20160022646
- Publication date Jan 28, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...
- Publication number 20150344886
- Publication date Dec 3, 2015
- ARROWHEAD RESEARCH CORPORATION
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
- Publication number 20150167002
- Publication date Jun 18, 2015
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

David P. Bingaman

Person

Patents Grantslast 30 patents

Ocular formulations for drug-delivery to the posterior segment of t...

Ocular formulations for drug-delivery and protection of the anterio...

Ocular formulations for drug-delivery to the posterior segment of t...

Ocular formulations for drug-delivery and protection of the anterio...

Ocular formulations for drug-delivery and protection of the anterio...

Ocular formulations for drug-delivery to the posterior segment of t...

RNAi-related inhibition of TNF-alpha signaling pathway for treatmen...

RNAi-related inhibition of TNF alpha signaling pathway for treatmen...

RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

RNAi-related inhibition of TNFα signaling pathway for treatment of...

RNAi-related inhibition of TNFα signaling pathway for treatment of...

Compositions and methods for treatment of angiogenesis-associated o...

RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis

5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocu...

Patents Applicationslast 30 patents

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

Ocular Formulations for Drug-Delivery and Protection of the Anterio...

Ocular Formulations for Drug-Delivery to the Posterior Segment of t...

RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS